In this video, I will talk about TransMedics (NASDAQ: TMDX) and the recent short-seller report. Watch the short video to learn more, consider subscribing, and click the special offer link below.

Philadelphia, Pennsylvania-- (Newsfile Corp. - January 10, 2025) - Kehoe Law Firm, P.C. is investigating potential securities class action claims on behalf of investors of TransMedics Group, Inc.

Shares of TransMedics Group (NASDAQ: TMDX) were tanking 14.3% lower as of 10:46 a.m. ET on Friday. The big sell-off came after activist short seller Scorpion Capital released a scathing report about ...

TransMedics Group Inc (TMDX) stock saw a decline, ending the day at $72.55 which represents a decrease of $-6.12 or -7.78% from the prior close of $78.67. The stock opened at $75.81 and touched a low ...

In a report released today, Suraj Kalia from Oppenheimer maintained a Buy rating on TransMedics Group (TMDX – Research Report), with a price ...

Shares of TransMedics Group, Inc. (NASDAQ:TMDX – Get Free Report) dropped 3.8% during trading on Thursday .The stock traded as low as $61.37 and last traded at $61.50. Approximately 93,896 ...

The Company's standard investor presentation is also available through this link. About TransMedics Group, Inc. TransMedics is the world's leader in portable extracorporeal warm perfusion and ...

TransMedics Group (NASDAQ:TMDX), a commercial-stage medical device company specializing in normothermic perfusion technology for organ transplants, stands at a critical juncture in its growth ...

TransMedics Group (NASDAQ:TMDX), a commercial-stage medical device company specializing in normothermic perfusion technology for organ transplants, stands at a critical juncture in its growth ...